Similarly, SEMMs were generated to investigate the synergistic effect of knocking out a tumor suppressor such as Pten and/or Trp53 together with the expression of an oncogene such as NRas or cMet (mutated or wild type) as well as the impact on tumor latency in HBV-driven models (9). The gene discussed is NRAS; the disease is neoplasm.